QGH

Electroconvulsive Therapy Device For Catatonia, Major Depressive Disorder, And Bipolar Disorder

Product code
QGH
Device name
Electroconvulsive Therapy Device For Catatonia, Major Depressive Disorder, And Bipolar Disorder
Device class
Class 2
21 CFR
21 CFR 882.5940
Medical specialty
Neurology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
9

FDA classification definition

Catatonia or a severe major depressive episode (MDE) associated with major depressive disorder (MDD) or bipolar disorder (BPD) in patients age 13 years and older who are treatment-resistant or who require a rapid response due to the severity of their psychiatric or medical condition.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: QGH
Classification and pathway per current FDA publications. Data from openFDA (CC0).